Douglas E. Hobson

1.6k total citations
29 papers, 1.2k citations indexed

About

Douglas E. Hobson is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Douglas E. Hobson has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Psychiatry and Mental health. Recurrent topics in Douglas E. Hobson's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Douglas E. Hobson is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (9 papers) and Botulinum Toxin and Related Neurological Disorders (5 papers). Douglas E. Hobson collaborates with scholars based in Canada, United States and South Korea. Douglas E. Hobson's co-authors include W. R. Wayne Martin, Anthony E. Lang, Ajmal Razmy, J. Rivest, Jonathan A.E. Fleming, Ned H. Cassem, Gregory L. Fricchione, William D. Leslie, Emmanuelle Pourcher and Lisa M. Lix and has published in prestigious journals such as JAMA, Neurology and Scientific Reports.

In The Last Decade

Douglas E. Hobson

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas E. Hobson Canada 16 768 259 251 217 184 29 1.2k
Merete Karlsborg Denmark 18 758 1.0× 180 0.7× 241 1.0× 112 0.5× 190 1.0× 35 1.1k
Ellen Trautmann Germany 12 646 0.8× 300 1.2× 294 1.2× 187 0.9× 113 0.6× 16 1.1k
Eric J. Pappert United States 18 977 1.3× 459 1.8× 166 0.7× 151 0.7× 243 1.3× 57 1.5k
Edvard Ehler Czechia 12 652 0.8× 101 0.4× 227 0.9× 144 0.7× 246 1.3× 40 1.1k
Pedro Schestatsky Brazil 20 447 0.6× 316 1.2× 77 0.3× 156 0.7× 167 0.9× 52 1.3k
Marcelo Mendonça Portugal 17 304 0.4× 128 0.5× 110 0.4× 217 1.0× 90 0.5× 48 890
Giulia Giannini Italy 24 934 1.2× 171 0.7× 185 0.7× 339 1.6× 306 1.7× 82 1.6k
Anna Zecchinelli Italy 24 1.1k 1.4× 133 0.5× 126 0.5× 186 0.9× 326 1.8× 46 1.5k
André C. Felício Brazil 23 860 1.1× 164 0.6× 118 0.5× 136 0.6× 471 2.6× 91 1.4k
Colin Klein Israel 14 480 0.6× 129 0.5× 123 0.5× 160 0.7× 138 0.8× 29 776

Countries citing papers authored by Douglas E. Hobson

Since Specialization
Citations

This map shows the geographic impact of Douglas E. Hobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Hobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Hobson more than expected).

Fields of papers citing papers by Douglas E. Hobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas E. Hobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Hobson. The network helps show where Douglas E. Hobson may publish in the future.

Co-authorship network of co-authors of Douglas E. Hobson

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas E. Hobson. A scholar is included among the top collaborators of Douglas E. Hobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas E. Hobson. Douglas E. Hobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lix, Lisa M., et al.. (2024). Determining the impact of specialized care on health outcomes and health care utilization in Parkinsonism. Parkinsonism & Related Disorders. 124. 106026–106026. 2 indexed citations
2.
Szturm, Tony, Andrew L. Goertzen, Douglas E. Hobson, et al.. (2021). Changes in Metabolic Activity and Gait Function by Dual-Task Cognitive Game-Based Treadmill System in Parkinson’s Disease: Protocol of a Randomized Controlled Trial. Frontiers in Aging Neuroscience. 13. 680270–680270. 5 indexed citations
3.
Jog, Mandar, J. Jack Lee, Astrid Scheschonka, et al.. (2020). Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study. Toxins. 12(12). 807–807. 21 indexed citations
4.
Modirrousta, Mandana, Sean Udow, Andrew Borys, et al.. (2020). Elevated caudate connectivity in cognitively normal Parkinson’s disease patients. Scientific Reports. 10(1). 17978–17978. 16 indexed citations
5.
Booth, Samuel, Douglas E. Hobson, Andrew Borys, et al.. (2019). Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients. Frontiers in Neurology. 10. 1217–1217. 13 indexed citations
6.
Postuma, Ronald B., Julius Anang, Amélie Pelletier, et al.. (2017). Caffeine as symptomatic treatment for Parkinson disease (Café-PD). Neurology. 89(17). 1795–1803. 98 indexed citations
7.
Graham, Jeffrey, Douglas E. Hobson, & Arjuna Ponnampalam. (2014). High affinity hemoglobin and Parkinson’s disease. Medical Hypotheses. 83(6). 819–821. 10 indexed citations
8.
Hobson, Douglas E.. (2011). Asymmetry in parkinsonism, spreading pathogens and the nose. Parkinsonism & Related Disorders. 18(1). 1–9. 20 indexed citations
9.
Lix, Lisa M., et al.. (2009). Socioeconomic variations in the prevalence and incidence of Parkinson's disease: a population-based analysis. Journal of Epidemiology & Community Health. 64(4). 335–340. 58 indexed citations
10.
Banno, Katsuhisa, Douglas E. Hobson, & Meir H. Kryger. (2005). Long-term treatment of sleep breathing disorder in a patient with Huntington's disease. Parkinsonism & Related Disorders. 11(4). 261–264. 9 indexed citations
11.
Hobson, Douglas E., Anthony E. Lang, W. R. Wayne Martin, et al.. (2002). Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease. JAMA. 287(4). 455–455. 423 indexed citations
12.
Leslie, William D., Cheryl R. Greenberg, Douglas N. Abrams, & Douglas E. Hobson. (1999). Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography. European Journal of Nuclear Medicine and Molecular Imaging. 26(11). 1458–1464. 4 indexed citations
13.
Hobson, Douglas E., Emmanuelle Pourcher, & W. R. Wayne Martin. (1999). Ropinirole and Pramipexole, the New Agonists. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 26(S2). S27–S33. 45 indexed citations
14.
Hobson, Douglas E., et al.. (1997). Botulinum Toxin Injection for Cervicogenic Headache. Headache The Journal of Head and Face Pain. 37(4). 253–255. 63 indexed citations
15.
Yamashiro, Yoshihiro, Bernard N. Chodirker, Douglas E. Hobson, & Meir H. Kryger. (1995). A Familial Awake Movement Disorder Mimicking Restless Legs in a Sleep Apnea Patient. SLEEP. 18(7). 604–607. 1 indexed citations
16.
Fénelon, Gilles, Avindra Nath, Douglas E. Hobson, et al.. (1994). Letters to the editor: LETTERS TO THE EDITOR. Movement Disorders. 9(1). 119–121. 1 indexed citations
17.
Nath, Avindra, et al.. (1993). Movement disorders with cerebral toxoplasmosis and AIDS. Movement Disorders. 8(1). 107–112. 42 indexed citations
18.
Hobson, Douglas E., et al.. (1987). Painless Glossopharyngeal “Neuralgia” with Syncope: A Case Report and Literature Review. Neurosurgery. 21(6). 916–919. 30 indexed citations
19.
Hobson, Douglas E., et al.. (1986). Primary Lymphoma of the Central Nervous System: Manitoba Experience and Literature Review. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 13(1). 55–61. 35 indexed citations
20.
Fricchione, Gregory L., et al.. (1983). Intravenous Lorazepam in Neuroleptic-Indueed Catatonia. Journal of Clinical Psychopharmacology. 3(6). 338???342–338???342. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Merete Karlsborg Breakdown of academic impact, for papers by Ellen Trautmann Breakdown of academic impact, for papers by Eric J. Pappert Breakdown of academic impact, for papers by Edvard Ehler Breakdown of academic impact, for papers by Pedro Schestatsky Breakdown of academic impact, for papers by Marcelo Mendonça Breakdown of academic impact, for papers by Giulia Giannini Breakdown of academic impact, for papers by Anna Zecchinelli Breakdown of academic impact, for papers by André C. Felício Breakdown of academic impact, for papers by Colin Klein
Rankless by CCL
2026